Alembic Pharmaceuticals Receives USFDA provisional Approval for Bosutinib Tablets
261 days ago
Alembic Pharmaceuticals Announced that it had received provisional Approval from the USFDA for Bosutinib Tablets that is used for cancer t....
Breaking Alembic Pharmaceuticals Stock News: Daily Updates and Key Developments
Get the latest Alembic Pharmaceuticals stock market news, including real-time updates, detailed analysis, and insights from financial experts. Stay ahead in the market with our comprehensive coverage.
Advertisement
Advertisement
Alembic Pharmaceuticals Reports 80% Surge in Net Profit: Boosts Investor Confidence
267 days ago
Alembic Pharmaceuticals reports an 80% surge in net profit for FY24, rising from ₹342 crore to ₹616 crore, driven by operational efficiencie....
USFDA Gives Nod to Icatibant Injection of Alembic Pharmaceuticals
274 days ago
USFDA gives the nod to Icatibant Injection Drug of Alembic Pharmaceuticals which will be used to treat the hereditary angioedema (HAE)....